Patent Box Legislation: What this means for Medtech R&D in Australia
The Patent Box regime is a tax concession that lowers the corporate tax rate for business pursuing new technological innovations in the medical & biomed space.
Home > R&D Tax Incentive > Page 4
The Patent Box regime is a tax concession that lowers the corporate tax rate for business pursuing new technological innovations in the medical & biomed space.
The Government is investing $111.9m for grants to enable Northern Australia based businesses to grow, diversify and create new jobs.
CSIRO’s working paper on quantifying returns found a $3.50 ROI and 10% avg annual return for every dollar invested in Australia.
The Export Assistance Grant provides exporting businesses in NSW with funding to help them access global markets.
In this article we’ll provide you with a summary of the major ongoing grants and programmes for R&D-focused businesses.
A chance to have your say in the development of this 10-year plan that seeks to leverage the exposure leading up to the 2032 Olympic Games to create innovation opportunities for the Sunshine State.
If claiming R&D Tax Incentive, you might prefer the financial certainty provided with a Advance Finding. For claiming overseas activities, it’s essential.
On 11 May 2021, the Government announced that the Board of Taxation would undertake a review to evaluate the dual-agency administration model for the Research and Development Tax Incentive (R&DTI).
The NZ R&D grant allows businesses to claim R&D costs incurred in Australia under certain requirements. Learn more about NZ’s RDTI here.
The CSIRO Kick-Start program is government funding for small and medium enterprises (SMEs), and can contribute between $10k and $50k matched spending for a CSIRO researcher to assist in an R&D project.
We will never share your details with any third-party.
Suite 63, 388 George St, Sydney NSW 2000
120 Spencer St Melbourne VIC 3000
310 Edward St Brisbane QLD 4000
1300 887 627
|